Showing results (131-140 of 1,055) with videos related to
Sort By:
Pageof 106
European Journal of Immunology|June 1, 1976
Lymphocyte proliferation in vitro induced by soluble protein antigens. II. Cellular requirementsB Hertel-Wulff, B RubinCutis|March 21, 2019
Granuloma annulare: a retrospective series of 133 patientsCourtney B Rubin, Misha RosenbachScandinavian Journal of Immunology|September 1, 1975
Biological significance of Fc receptor-bearing cells among activated T lymphocytesB Rubin, B Hertel-WulffJournal of the Neurological Sciences|March 28, 2021
Neurological complications of cancer immunotherapy (CAR T cells)Daniel B Rubin, Henrikas VaitkeviciusResearch Square|July 18, 2023
Accounting for sex differences as a continuous variable in cancer treatmentsWei Yang, Joshua B RubinStatistics in Medicine|May 28, 2015
Estimation of causal effects of binary treatments in unconfounded studiesRoee Gutman, Donald B RubinThe Journal of Biological Chemistry|February 5, 1992
cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteasesD Marguet, A M Bernard, I Vivier, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1980
Idiotypic analysis of anti-GAT antibodies. VII. Common idiotype on hybridoma antibodies to poly(Glu60 Ala40)S T Ju, M Pierres, R N Germain, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
Processing by accessory cells for presentation to murine T cells of apamin, a disulfide-bonded 18 amino acid peptideA Régnier-Vigouroux, M el Ayeb, M L Defendini, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1990
Characterization of the neutral aminopeptidase activity associated to the mouse thymocyte-activating moleculeJ P Gorvel, I Vivier, P Naquet, et al.Pageof 106